Miebo vs. Restasis

If you’ve been prescribed treatment for dry eye, you may come across two very different options: Miebo and Restasis.

Both are FDA-approved prescription eye drops—but they don’t work the same way, and they’re often used for different types of dry eye.

So how do they compare?

Let’s break it down.

First, the key difference

At a high level:

• Miebo (perfluorohexyloctane) targets tear evaporation
• Restasis (cyclosporine) targets inflammation

👉 Same condition, completely different approach

How Miebo works

Miebo is designed for evaporative dry eye, which is often linked to meibomian gland dysfunction (MGD).

• It contains perfluorohexyloctane, a water-free, lipid-like substance
• Spreads across the eye’s surface
• Forms a protective layer that helps prevent tears from evaporating

In simple terms:
👉 Miebo helps keep the tears you already have from disappearing too quickly

How Restasis works

Restasis is an immunomodulator (cyclosporine) that targets inflammation.

• Reduces inflammation in the tear-producing glands
• Helps increase natural tear production over time

In simple terms:
👉 Restasis helps your eyes produce more of their own tears

Evaporative vs. inflammatory dry eye

Dry eye isn’t just one condition—it can have different root causes.

Evaporative dry eye (Miebo)

• Tears evaporate too quickly
• Often caused by oil gland dysfunction (MGD)
• Symptoms:
  • Burning
  • Fluctuating vision
  • Dryness that returns quickly

Inflammatory dry eye (Restasis)

• Tear production is reduced due to inflammation
• Often tied to immune system activity
• Symptoms:
  • Chronic dryness
  • Irritation
  • Reduced tear volume

👉 Many patients actually have a mix of both

Onset of action: how fast they work

Miebo:

• Works physically on the tear film
• Some patients notice improvement relatively quickly (days to weeks)

Restasis:

• Works by modifying the immune response
• Typically takes 3–6 months for full effect

👉 In simple terms:

• Miebo = faster surface-level support
• Restasis = slower, long-term change

Dosing differences

• Miebo:
  Typically 4 times daily
• Restasis:
  Typically twice daily

Consistency is key with both.

Side effects: what’s different

Miebo:

• Temporary blurred vision
• Mild eye irritation
• Eye redness

Restasis:

• Burning or stinging upon application
• Eye redness
• Watery eyes

Both are generally well tolerated, but the experience can feel different.

Which patients may benefit from each?

Miebo may be a better fit if:

• You have evaporative dry eye
• You’ve been told you have MGD
• Artificial tears don’t last long
• Your symptoms come and go quickly

Restasis may be a better fit if:

• You have low tear production
• Inflammation is a primary driver
• You’re looking for long-term tear improvement

👉 The right choice depends on the underlying cause—not just the symptoms

Can you use Miebo and Restasis together?

In some cases, yes.

Because they work differently:

• Miebo supports the tear film (oil layer)
• Restasis supports tear production and inflammation control

👉 Some providers may recommend using both as part of a broader dry eye plan

That said, this should always be guided by a clinician.

The bottom line

Miebo and Restasis aren’t competing—they’re complementary tools for different aspects of dry eye.

• Miebo: targets evaporation and tear stability
• Restasis: targets inflammation and tear production

Understanding your type of dry eye is the key to choosing the right approach.

A note from us

At Peeq, we’re not medical providers—but we believe patients should understand what’s actually driving their symptoms.

Prescription drops can play a powerful role—but dry eye is usually multifactorial. Long-term relief often comes from combining the right treatments with consistent daily habits like lid hygiene and tear support.